The upregulation of PD-L1 or CTLA-4 expression can mediate the escape of tumor cells from the host immune response, lead to an immunosuppressive state, and inhibit the antitumor immune response in some tumor microenvironments [62]. This evidence concerns the gene CTLA4 and neoplasm.